Mylan Inc. today announced that, it has entered into a settlement agreement with Novartis Pharmaceuticals Corp., Novartis Corp. and Novartis International AG related to Letrozole Tablets, the generic version of Novartis' Femara(R).
The details can be read here.
No comments:
Post a Comment